4//SEC Filing
ASADORIAN RAFFI 4
Accession 0001209191-23-007817
CIK 0001427925other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:48 PM ET
Size
5.2 KB
Accession
0001209191-23-007817
Insider Transaction Report
Form 4
ASADORIAN RAFFI
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2023-02-06$2.02/sh−617$1,246→ 17,589 total
Footnotes (3)
- [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]Reflects a 1-20 reverse stock split which became effective on October 25, 2022.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001628970
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:48 PM ET
- Size
- 5.2 KB